GROUP ONE TRADING, L.P. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 43 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$27,392
-97.8%
10,495
-89.7%
0.00%
-100.0%
Q4 2022$1,227,866
+383.4%
102,067
+160.7%
0.00%
Q3 2022$254,000
+586.5%
39,157
+387.9%
0.00%
Q2 2022$37,000
-54.3%
8,026
+41.9%
0.00%
Q4 2021$81,000
-56.5%
5,655
-33.3%
0.00%
Q3 2021$186,000
+376.9%
8,474
+187.9%
0.00%
Q2 2021$39,000
+3800.0%
2,943
+729.0%
0.00%
Q3 2020$1,000
-98.0%
355
-97.9%
0.00%
Q4 2018$51,000
-37.8%
16,9000.0%0.00%
-100.0%
Q3 2018$82,000
-20.4%
16,900
+47.3%
0.00%0.0%
Q4 2017$103,000
+37.3%
11,477
+50.9%
0.00%0.0%
Q3 2017$75,000
+368.8%
7,605
+280.2%
0.00%
Q2 2017$16,000
+33.3%
2,0000.0%0.00%
Q1 2017$12,000
-61.3%
2,000
-60.0%
0.00%
Q4 2016$31,000
-53.7%
5,000
-50.1%
0.00%
-100.0%
Q1 2016$67,000
-55.9%
10,030
-43.7%
0.00%
-50.0%
Q4 2015$152,000
+3700.0%
17,828
+2379.6%
0.00%
Q2 2015$4,000
-77.8%
719
-74.2%
0.00%
Q1 2015$18,000
+157.1%
2,791
+74.9%
0.00%
Q4 2014$7,000
-78.8%
1,596
-61.0%
0.00%
-100.0%
Q3 2014$33,000
+32.0%
4,096
+60.6%
0.00%
Q2 2014$25,000
-30.6%
2,550
-17.5%
0.00%
-100.0%
Q1 2014$36,0003,0910.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders